Using the hospital anxiety and depression scale in people with epilepsy: Is overlapping symptomatology a problem?

The Hospital Anxiety and Depression Scale (HADS) is designed to screen for anxiety and depression in clinical settings. However, some items on the HADS may reflect symptoms associated with epilepsy and antiseizure medications rather than anxiety and depression. This study examined whether these item...

Full description

Bibliographic Details
Main Authors: Elisa Tye, Sallie Baxendale
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Epilepsy & Behavior Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S258998642300059X
_version_ 1827332129735835648
author Elisa Tye
Sallie Baxendale
author_facet Elisa Tye
Sallie Baxendale
author_sort Elisa Tye
collection DOAJ
description The Hospital Anxiety and Depression Scale (HADS) is designed to screen for anxiety and depression in clinical settings. However, some items on the HADS may reflect symptoms associated with epilepsy and antiseizure medications rather than anxiety and depression. This study examined whether these items on the HADS contributed disproportionately to the reporting of anxiety and depression on the HADS in people with epilepsy (PWE). As part of a routine clinical assessment, 546 adults with epilepsy completed the HADS. In our sample, 56.2% reported elevated levels of anxiety, and 27.3% reported symptoms of depression with a score of 8 or more on the respective subscales. Scores on the anxiety and depression subscales were not associated with age, sex or epilepsy type. We did not find a relationship between endorsement of items related to panic, feelings of dread or butterflies in the stomach and a diagnosis of temporal lobe epilepsy. The most frequently endorsed item on the anxiety subscale of the HADS in the sample as a whole related to worrying thoughts, rather than the more somatic manifestations of anxiety. The item ‘I feel as if I am slowed down’ was endorsed by the majority of people with epilepsy and may not reflect a symptom of depression in this group. Careful analyses of the pattern of endorsement of specific items on the HADS may improve the sensitivity of this screening measure to the presence of depression in people with epilepsy.
first_indexed 2024-03-07T16:53:24Z
format Article
id doaj.art-c4b0ac198f994077945b616d56318e2a
institution Directory Open Access Journal
issn 2589-9864
language English
last_indexed 2024-03-07T16:53:24Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Epilepsy & Behavior Reports
spelling doaj.art-c4b0ac198f994077945b616d56318e2a2024-03-03T04:30:04ZengElsevierEpilepsy & Behavior Reports2589-98642024-01-0125100641Using the hospital anxiety and depression scale in people with epilepsy: Is overlapping symptomatology a problem?Elisa Tye0Sallie Baxendale1University College Hospital, London, United KingdomUniversity College Hospital, London, United Kingdom; UCL Queen Square Institute of Neurology, Department of Clinical and Experimental Epilepsy, United Kingdom; Corresponding author at: University College Hospital, London, United Kingdom.The Hospital Anxiety and Depression Scale (HADS) is designed to screen for anxiety and depression in clinical settings. However, some items on the HADS may reflect symptoms associated with epilepsy and antiseizure medications rather than anxiety and depression. This study examined whether these items on the HADS contributed disproportionately to the reporting of anxiety and depression on the HADS in people with epilepsy (PWE). As part of a routine clinical assessment, 546 adults with epilepsy completed the HADS. In our sample, 56.2% reported elevated levels of anxiety, and 27.3% reported symptoms of depression with a score of 8 or more on the respective subscales. Scores on the anxiety and depression subscales were not associated with age, sex or epilepsy type. We did not find a relationship between endorsement of items related to panic, feelings of dread or butterflies in the stomach and a diagnosis of temporal lobe epilepsy. The most frequently endorsed item on the anxiety subscale of the HADS in the sample as a whole related to worrying thoughts, rather than the more somatic manifestations of anxiety. The item ‘I feel as if I am slowed down’ was endorsed by the majority of people with epilepsy and may not reflect a symptom of depression in this group. Careful analyses of the pattern of endorsement of specific items on the HADS may improve the sensitivity of this screening measure to the presence of depression in people with epilepsy.http://www.sciencedirect.com/science/article/pii/S258998642300059XAnxietyDepressionEpilepsySlowingScreening
spellingShingle Elisa Tye
Sallie Baxendale
Using the hospital anxiety and depression scale in people with epilepsy: Is overlapping symptomatology a problem?
Epilepsy & Behavior Reports
Anxiety
Depression
Epilepsy
Slowing
Screening
title Using the hospital anxiety and depression scale in people with epilepsy: Is overlapping symptomatology a problem?
title_full Using the hospital anxiety and depression scale in people with epilepsy: Is overlapping symptomatology a problem?
title_fullStr Using the hospital anxiety and depression scale in people with epilepsy: Is overlapping symptomatology a problem?
title_full_unstemmed Using the hospital anxiety and depression scale in people with epilepsy: Is overlapping symptomatology a problem?
title_short Using the hospital anxiety and depression scale in people with epilepsy: Is overlapping symptomatology a problem?
title_sort using the hospital anxiety and depression scale in people with epilepsy is overlapping symptomatology a problem
topic Anxiety
Depression
Epilepsy
Slowing
Screening
url http://www.sciencedirect.com/science/article/pii/S258998642300059X
work_keys_str_mv AT elisatye usingthehospitalanxietyanddepressionscaleinpeoplewithepilepsyisoverlappingsymptomatologyaproblem
AT salliebaxendale usingthehospitalanxietyanddepressionscaleinpeoplewithepilepsyisoverlappingsymptomatologyaproblem